Bi-Cheng Liu is a Chair Professor and Dean of School of Medicine, head of Insitute  of  Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China. He is also the Vice President of Chinese Society of Nephrology and Vice President of Chinese Society of Renal Physiology.

• Part I: ESA hyporesponsive CKD anemia.- Chapter 1 Treatment of a patient with severe anemia and systemic lupus erythematosus.- Chapter 2 Application of roxadustat in a patient with renal anemia.- Chapter 3 Roxadustat on renal anemia in patients with maintenance hemodialysis.- Chapter 4 Treatment of renal anemia in a peritoneal dialysis patient with low erythropoietic response.- Chapter 5 Treatment of anemia in a multiple myeloma patient with deep vein thrombosis in lower limb.- Chapter 6 Treatment of a Patient with Peritoneal Dialysis Combined with Erythropoietin-hyporesponsive Anemia.- Chapter 7 Roxadustat for the treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report.- Part II: CKD anemia with PRCA.- Chapter 8 Anti-erythropoietin antibody-mediated pure red cell aplasia.- Chapter 9 Treatment of erythropoietin-induced pure red cell aplastic anemia.- Part III: CKD anemia with inflammation or infection.- Chapter 10 Anemia treatment with roxadustat in a peritoneal dialysis patients during Omicron virus infection: A case report.- Chapter 11 Use of a hypoxia-inducible factor prolyl hydroxylase inhibitor in a peritoneal dialysis patient with coronavirus disease 2019.- Chapter 12 Treatment of severe anemia in a patient with acute peritonitis undergoing hemodialysis combined with peritoneal dialysis.- Chapter 13 Erythropoietin was used to treat anemia in a patient on maintenance hemodialysis.- Chapter 14 COVID-19 exacerbated renal anemia in a maintenance hemodialysis patient.- Chapter 15 Treatment of Anemia Complicated with Severe Infection in a He-modialysis Patient.- Chapter 16 Treatment of renal anemia in a patient undergoing maintenance heemodialysis who had viral hepatitis B infection.- Chapter 17 Treatment of renal anemia due to chronic interstitial nephritis.- Part IV: CKD anemia combined with other complex disease .- Chapter 18 Treatment of severe anemia in a hemodialysis patient with bone marrow hypoplasia.- Chapter 19 Treatment of severe renal anemia in a hemodialysis patient with decompensation of liver cirrhosis and irregular positive erythrocyte antibody.- Chapter 20 Treatment of anemia in a lupus nephritis patient with renal insufficiency, infection and bone marrow hypoplasia.- Chapter 21 Effect of roxadustat on glucose and lipid metabolism in a patient on peritoneal dialysis with renal anemia.- Chapter 22 Treatment of renal anemia with chronic blood loss in peritoneal dialysis patients.- Chapter 23 A case of cardiorenal anemia syndrome complicated with malignant hypertension.- Chapter 24 Roxadustat in the treatment of renal anemia in a hemodialysis patient.- Chapter 25 Roxadustat quickly corrected anemia in a peritoneal dialysis patient and increased perioperative safety.- Chapter 26 Roxadustat for the treatment of refractory anemia in a hemodialysis patient: A case report.- Chapter 27 Treatment of anemia in a patient with chronic kidney disease and cerebral infarction.- Chapter 28 Treatment of refractory anemia in a patient with end-stage renal disease and a postoperative bladder tumor.- Chapter 29 The role of intravenous iron supplementation in the treatment of renal anemia with roxadustat.- Chapter 30 Roxadustat for anemia in a patient with chronic kidney disease not receiving dialysis.- Chapter 31 Treatment of severe anemia in a MPO-ANCA and anti-GBM double-seropositive patient.- Chapter 32 Is roxadustat responsible for the jaundice of a dialysis patient with β-thalassemia? A case report.- Chapter 33 One case of peritoneal dialysis complicated with refractory hyper-tension and renal anemia.- Chapter 34 Roxadustat Corrects Acute Phosphate Nephropathy with Concur-rent Renal Anemia: A Case Report.- Chapter 35 One patient with renal anemia complicated with hyperferritinemia.

Bi-Cheng Liu is a Chair Professor and Dean of School of Medicine, head of Insitute  of  Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China. He is also the Vice President of Chinese Society of Nephrology and Vice President of Chinese Society of Renal Physiology.

• Part I: ESA hyporesponsive CKD anemia.- Chapter 1 Treatment of a patient with severe anemia and systemic lupus erythematosus.- Chapter 2 Application of roxadustat in a patient with renal anemia.- Chapter 3 Roxadustat on renal anemia in patients with maintenance hemodialysis.- Chapter 4 Treatment of renal anemia in a peritoneal dialysis patient with low erythropoietic response.- Chapter 5 Treatment of anemia in a multiple myeloma patient with deep vein thrombosis in lower limb.- Chapter 6 Treatment of a Patient with Peritoneal Dialysis Combined with Erythropoietin-hyporesponsive Anemia.- Chapter 7 Roxadustat for the treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report.- Part II: CKD anemia with PRCA.- Chapter 8 Anti-erythropoietin antibody-mediated pure red cell aplasia.- Chapter 9 Treatment of erythropoietin-induced pure red cell aplastic anemia.- Part III: CKD anemia with inflammation or infection.- Chapter 10 Anemia treatment with roxadustat in a peritoneal dialysis patients during Omicron virus infection: A case report.- Chapter 11 Use of a hypoxia-inducible factor prolyl hydroxylase inhibitor in a peritoneal dialysis patient with coronavirus disease 2019.- Chapter 12 Treatment of severe anemia in a patient with acute peritonitis undergoing hemodialysis combined with peritoneal dialysis.- Chapter 13 Erythropoietin was used to treat anemia in a patient on maintenance hemodialysis.- Chapter 14 COVID-19 exacerbated renal anemia in a maintenance hemodialysis patient.- Chapter 15 Treatment of Anemia Complicated with Severe Infection in a He-modialysis Patient.- Chapter 16 Treatment of renal anemia in a patient undergoing maintenance heemodialysis who had viral hepatitis B infection.- Chapter 17 Treatment of renal anemia due to chronic interstitial nephritis.- Part IV: CKD anemia combined with other complex disease .- Chapter 18 Treatment of severe anemia in a hemodialysis patient with bone marrow hypoplasia.- Chapter 19 Treatment of severe renal anemia in a hemodialysis patient with decompensation of liver cirrhosis and irregular positive erythrocyte antibody.- Chapter 20 Treatment of anemia in a lupus nephritis patient with renal insufficiency, infection and bone marrow hypoplasia.- Chapter 21 Effect of roxadustat on glucose and lipid metabolism in a patient on peritoneal dialysis with renal anemia.- Chapter 22 Treatment of renal anemia with chronic blood loss in peritoneal dialysis patients.- Chapter 23 A case of cardiorenal anemia syndrome complicated with malignant hypertension.- Chapter 24 Roxadustat in the treatment of renal anemia in a hemodialysis patient.- Chapter 25 Roxadustat quickly corrected anemia in a peritoneal dialysis patient and increased perioperative safety.- Chapter 26 Roxadustat for the treatment of refractory anemia in a hemodialysis patient: A case report.- Chapter 27 Treatment of anemia in a patient with chronic kidney disease and cerebral infarction.- Chapter 28 Treatment of refractory anemia in a patient with end-stage renal disease and a postoperative bladder tumor.- Chapter 29 The role of intravenous iron supplementation in the treatment of renal anemia with roxadustat.- Chapter 30 Roxadustat for anemia in a patient with chronic kidney disease not receiving dialysis.- Chapter 31 Treatment of severe anemia in a MPO-ANCA and anti-GBM double-seropositive patient.- Chapter 32 Is roxadustat responsible for the jaundice of a dialysis patient with β-thalassemia? A case report.- Chapter 33 One case of peritoneal dialysis complicated with refractory hyper-tension and renal anemia.- Chapter 34 Roxadustat Corrects Acute Phosphate Nephropathy with Concur-rent Renal Anemia: A Case Report.- Chapter 35 One patient with renal anemia complicated with hyperferritinemia.

Bi-Cheng Liu is a Chair Professor and Dean of School of Medicine, head of Insitute  of  Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China. He is also the Vice President of Chinese Society of Nephrology and Vice President of Chinese Society of Renal Physiology.

• Part I: ESA hyporesponsive CKD anemia.- Chapter 1 Treatment of a patient with severe anemia and systemic lupus erythematosus.- Chapter 2 Application of roxadustat in a patient with renal anemia.- Chapter 3 Roxadustat on renal anemia in patients with maintenance hemodialysis.- Chapter 4 Treatment of renal anemia in a peritoneal dialysis patient with low erythropoietic response.- Chapter 5 Treatment of anemia in a multiple myeloma patient with deep vein thrombosis in lower limb.- Chapter 6 Treatment of a Patient with Peritoneal Dialysis Combined with Erythropoietin-hyporesponsive Anemia.- Chapter 7 Roxadustat for the treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report.- Part II: CKD anemia with PRCA.- Chapter 8 Anti-erythropoietin antibody-mediated pure red cell aplasia.- Chapter 9 Treatment of erythropoietin-induced pure red cell aplastic anemia.- Part III: CKD anemia with inflammation or infection.- Chapter 10 Anemia treatment with roxadustat in a peritoneal dialysis patients during Omicron virus infection: A case report.- Chapter 11 Use of a hypoxia-inducible factor prolyl hydroxylase inhibitor in a peritoneal dialysis patient with coronavirus disease 2019.- Chapter 12 Treatment of severe anemia in a patient with acute peritonitis undergoing hemodialysis combined with peritoneal dialysis.- Chapter 13 Erythropoietin was used to treat anemia in a patient on maintenance hemodialysis.- Chapter 14 COVID-19 exacerbated renal anemia in a maintenance hemodialysis patient.- Chapter 15 Treatment of Anemia Complicated with Severe Infection in a He-modialysis Patient.- Chapter 16 Treatment of renal anemia in a patient undergoing maintenance heemodialysis who had viral hepatitis B infection.- Chapter 17 Treatment of renal anemia due to chronic interstitial nephritis.- Part IV: CKD anemia combined with other complex disease .- Chapter 18 Treatment of severe anemia in a hemodialysis patient with bone marrow hypoplasia.- Chapter 19 Treatment of severe renal anemia in a hemodialysis patient with decompensation of liver cirrhosis and irregular positive erythrocyte antibody.- Chapter 20 Treatment of anemia in a lupus nephritis patient with renal insufficiency, infection and bone marrow hypoplasia.- Chapter 21 Effect of roxadustat on glucose and lipid metabolism in a patient on peritoneal dialysis with renal anemia.- Chapter 22 Treatment of renal anemia with chronic blood loss in peritoneal dialysis patients.- Chapter 23 A case of cardiorenal anemia syndrome complicated with malignant hypertension.- Chapter 24 Roxadustat in the treatment of renal anemia in a hemodialysis patient.- Chapter 25 Roxadustat quickly corrected anemia in a peritoneal dialysis patient and increased perioperative safety.- Chapter 26 Roxadustat for the treatment of refractory anemia in a hemodialysis patient: A case report.- Chapter 27 Treatment of anemia in a patient with chronic kidney disease and cerebral infarction.- Chapter 28 Treatment of refractory anemia in a patient with end-stage renal disease and a postoperative bladder tumor.- Chapter 29 The role of intravenous iron supplementation in the treatment of renal anemia with roxadustat.- Chapter 30 Roxadustat for anemia in a patient with chronic kidney disease not receiving dialysis.- Chapter 31 Treatment of severe anemia in a MPO-ANCA and anti-GBM double-seropositive patient.- Chapter 32 Is roxadustat responsible for the jaundice of a dialysis patient with β-thalassemia? A case report.- Chapter 33 One case of peritoneal dialysis complicated with refractory hyper-tension and renal anemia.- Chapter 34 Roxadustat Corrects Acute Phosphate Nephropathy with Concur-rent Renal Anemia: A Case Report.- Chapter 35 One patient with renal anemia complicated with hyperferritinemia.